Fibromyalgia Treatment Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Antidepressants, Antiepileptic, Muscle Relaxants, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Regional Forecast, 2026-2034

  ATTRIBUTE

  DETAILS

Study Period

  2021-2034

Base Year  

  2025

Forecast Period

  2026-2034

Historical Period

  2021-2024

Unit

  Value (USD Million)

Segmentation

  Drug Class, Distribution Channel, and Region

By Drug Class

• Antidepressants
• Antiepileptic
• Muscle Relaxants
• Others (incl. Pipeline Products)

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

By Geography

• North America
  • By Drug Class
  • By Distribution Channel
  • By Country
    • USA (By Drug Class)
    •  Canada (By Drug Class)
• Europe
  • By Drug Class
  • By Distribution Channel
  • By Country
    • UK (By Drug Class)
    • Germany (By Drug Class)
    • France (By Drug Class)
    • Italy (By Drug Class)
    • Spain (By Drug Class)
    • Scandinavia (By Drug Class)
    • Rest of Europe (By Drug Class)
• Asia Pacific
  • By Drug Class
  • By Distribution Channel
  • By Country
    • Japan (By Drug Class)
    • China (By Drug Class)
    • India (By Drug Class)
    • Australia (By Drug Class)
    • Southeast Asia (By Drug Class)
    • Rest of Asia Pacific (By Drug Class)
• Latin America
  • By Drug Class
  • By Distribution Channel
  • By Country
    • Brazil (By Drug Class)
    • Mexico (By Drug Class)
    • Rest of Latin America (By Drug Class)
• Middle East & Africa
  • By Drug Class
  • By Distribution Channel
  • By Country
    • GCC (By Drug Class)
    • South Africa (By Drug Class)
    • Rest of MEA (By Drug Class)